Name: Staphylococcus aureus F-182
Creator: BacDive
License: http://creativecommons.org/licenses/by-nc/4.0/

Strain identifier

BacDive ID: 14464

Type strain:

Species: Staphylococcus aureus

Strain Designation: F-182

Culture col. no.: DSM 13661, ATCC 43300, CCUG 41586, LMG 15975, WDCM 00211

Strain history: <- CCUG; CCUG 41586 <- BCCM; LMG 15975 <- ATCC; ATCC 43300 <- C. Thornsberry; F-182

NCBI tax ID(s): 1280 (species)

SI-ID 13985

LMG 15975, ATCC 43300, CCM 4750, DSM 13661, CCUG 41586, CECT 5190, NCCB 90037, LMD 90.37, BCRC 14979, CCRC 14979, ACM 5202, CNCTC 6271

Other strains from Staphylococcus aureus

Section

Staphylococcus aureus F-182 is a mesophilic, Gram-positive human pathogen that has multiple antibiotic resistances and was isolated from human clinical.

antibiotic resistance
Gram-positive
human pathogen
mesophilic
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Bacillota*
	Class	*Bacilli*
	Order	*Caryophanales*
	Family	*Staphylococcaceae*
	Genus	*Staphylococcus*
	Species	**Staphylococcus aureus**
	Full Scientific Name (LPSN)	Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980)

Synonym

Staphylococcus aureus subsp. anaerobius

Information on morphological and physiological properties Morphology

[Ref.: #69480]	Gram stain	positive Confidence in %100

[Ref.: #5032]

Incubation period

1-2 days

Information on culture and growth conditions Culture and growth conditions

[Ref.: #5032]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #5032]

Culture medium growth

[Ref.: #5032]

Culture medium link

Medium recipe at MediaDive

[Ref.: #5032]

Culture medium composition

expand / minimize

[Ref.: #5032]

Culture medium

TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)

[Ref.: #5032]

Culture medium growth

[Ref.: #5032]

Culture medium link

Medium recipe at MediaDive

[Ref.: #5032]

Culture medium composition

expand / minimize

	Temperatures	Kind of temperature		Temperature
[Ref.: #5032]			growth	37 °C

[Ref.: #5032]

Temperature range

mesophilic

Information on physiology and metabolism Physiology and metabolism

Note that the displayed test results represent raw data and therefore may deviate!

Antibiotic susceptibility testing

Test 1

Test 2

Test 3

Test 4

Test 5

Test 6

Test 7

Test 8

Test 9

Test 10

Test 11

Test 12

Reference

[Ref.: #5032]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
12
8
12
16-18
12
28
16
18
resistant0
40
32
26
10
22
18
resistant0
resistant0
26
24-26
10
10
24
16
6-8
6
10
34
12
resistant0
30
30
34
resistant0
28
18
14-16

[Ref.: #5032]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
10
8-10
10
16
12
28
28
14
resistant0
40
34-36
28
10
20
20
resistant0
resistant0
28
26
resistant0
10
24
16
8
8
12
36
12
resistant0
30-32
30
34
resistant0
28
18
16

[Ref.: #5032]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
10
8-10
10
16
12
28
28
14
resistant0
40
34-36
28
10
20
20
resistant0
resistant0
28
26
resistant0
10
24
16
8
8
12
36
12
resistant0
30-32
30
34
resistant0
28
18
16

[Ref.: #5032]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
14
22
14
18-20
14
30
28
18
resistant0
42-44
34
30
10
20
20-22
resistant0
resistant0
30
26
10
8
28
20
10
6
10-12
36
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #5032]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
14
20-22
14
18-20
14
28-30
26
16-18
resistant0
42-44
36
28-30
10
18
20
resistant0
resistant0
30
26
resistant0
8
24-26
20
10
6
12
36
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #5032]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
12
20-22
12
16-18
12-14
30
28
18-20
resistant0
44
36
30
10
20
20-22
resistant0
resistant0
30
26-28
10
6-8
26
20
8-10
8
10-12
36-38
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #5032]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
10-12
20
12
16
12
28
26-28
16-18
resistant0
42-44
36
30
12
20
22
resistant0
resistant0
28
26
resistant0
6-8
24-26
20
10
6
12
36
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #5032]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
8
resistant0
10
10
10
resistant0
6
10
resistant0
32
18
16
8
12
12
resistant0
resistant0
18
20
resistant0
6
18
12
resistant0
resistant0
resistant0
18
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #5032]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
14
16
14
18
14
26-28
26
18-20
resistant0
42-44
30-32
26-28
12
20
20
resistant0
resistant0
28
28
resistant0
10
24
18
10-12
20
12
32
16
resistant0
30
32
30
resistant0
28
18
16

[Ref.: #5032]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
12
8
14
20
14
28-30
28-30
20
resistant0
44-46
36
30
10
22-24
22
resistant0
resistant0
28
26
resistant0
8
26
20
8
resistant0
12
34
16
resistant0
34
34
36
resistant0
30
20
18

[Ref.: #5032]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
14
20-22
14
18-20
12
30
28-30
18-20
resistant0
46
34
30
20
20
20
resistant0
resistant0
28-30
28
resistant0
10
28
20
10
8
12
32-34
14
resistant0
36
34
30
resistant0
28
20
16-18

[Ref.: #5032]
Mueller Hinton
37

aerob
yes
Inhibition zone diameter in mm
12
8
12
18
12
24
18
16
resistant0
42
32-34
28
10
20
20
resistant0
resistant0
28
24
resistant0
8
24
16-18
6-8
8
12-14
34
14
resistant0
32
30
36
resistant0
30
20
16

Only first 15 entries are displayed. Click here to see all.

[Ref.: #69481]	Ability of spore formation	no Confidence in %91
[Ref.: #69480]	Ability of spore formation	no Confidence in %99.909

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68375]	arabinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	arginine ChEBI	+	hydrolysis	* from API ID32STA
[Ref.: #68375]	cellobiose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	D-fructose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	D-glucose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	D-mannitol ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	D-mannose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	esculin ChEBI	-	hydrolysis	* from API ID32STA
[Ref.: #68375]	lactose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	maltose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	N-acetylglucosamine ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	nitrate ChEBI	+	reduction	* from API ID32STA
[Ref.: #68375]	ornithine ChEBI	-	degradation	* from API ID32STA
[Ref.: #68375]	raffinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	sucrose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	trehalose ChEBI	+	fermentation	* from API ID32STA
	Only first 10 entries are displayed. Click here to see all.

	Enzyme	Enzyme activity	EC number
[Ref.: #68375]	alkaline phosphatase	+	3.1.3.1	* from API ID32STA
[Ref.: #68375]	arginine dihydrolase	+	3.5.3.6	* from API ID32STA
[Ref.: #68375]	beta-glucosidase	-	3.2.1.21	* from API ID32STA
[Ref.: #68375]	beta-glucuronidase	-	3.2.1.31	* from API ID32STA
[Ref.: #5032]	catalase	+	1.11.1.6
[Ref.: #5032]	cytochrome-c oxidase	-	1.9.3.1
[Ref.: #68375]	L-arginine arylamidase	-		* from API ID32STA
[Ref.: #68375]	ornithine decarboxylase	-	4.1.1.17	* from API ID32STA

API® ID32STA:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Urease/urea hydrolysisURE	Arginine dihydrolaseADH (Arg)	Ornithine decarboxylaseODC	Esculin hydrolysisESC	Fermentation of D-glucoseGLU	Fermentation of D-fructoseFRU	Fermentation of D-mannoseMNE	Fermentation of maltoseMAL	Fermentation of lactoseLAC	Fermentation of trehaloseTRE	Fermentation of D-mannitolMAN	Fermentation of raffinoseRAF	Fermentation of D-riboseRIB	Fermentation of cellobioseCEL	Reduction of nitrateNIT	Acetoin production (Voges Proskauer test)VP	beta-Galactosidasebeta GAL	L-arginine arylamidaseArgA	Alkaline phosphatasePAL	Pyrrolidonyl arylamidasePyrA	Novobiocin resistanceNOVO	Fermentation of sucroseSAC	Fermentation of N-acetyl-glucosamineNAG	Fermentation of turanoseTUR	Fermentation of arabinoseARA	beta-Glucuronidasebeta GUR
[Ref.: #5032]	6274	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	-	+	+	+	-	-
[Ref.: #5032]	5866	-	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	-	+	+	+	+	-	-
[Ref.: #5032]	5867	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	-	+	+	+	+	-	-
[Ref.: #5032]	5868	-	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	+	-	+	-	+	+	+	+	-	-
[Ref.: #5032]	5869	-	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	-	+	+	+	+	-	-
[Ref.: #5032]	5870	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	-	+/-	+	+	+/-	-	-
[Ref.: #5032]	5871	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	not determinedn.d.	-	-	+	-	-	+	+	+	-	-
[Ref.: #5032]	5872	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	-	-	+	+	+	-	-
[Ref.: #55134]	2171	-	+	-	-	+	+	+	+	+	+	+	-	-	-	+	-	-	-	+	-	-	+	+	+	-	-
[Ref.: #5032]	6202	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	-	+	+	+	+	-	-
[Ref.: #5032]	6231	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	-	+	+	+	-	-
[Ref.: #5032]	6355	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	-	-	+	+	+	-	-

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #5032]	Sample type/isolated from	human clinical
[Ref.: #5032]	Geographic location (country and/or sea, region)	Kansas
[Ref.: #5032]	Country	USA
[Ref.: #5032]	Country ISO 3 Code	USA
[Ref.: #5032]	Continent	North America
[Ref.: #5032]	Geographic location	38.4500°/-96.5333°

[Ref.: #55134]	Sample type/isolated from	Human clinical isolate
[Ref.: #55134]	Geographic location (country and/or sea, region)	Kansas
[Ref.: #55134]	Country	USA
[Ref.: #55134]	Country ISO 3 Code	USA
[Ref.: #55134]	Continent	North America
* marker position based on {}

Isolation sources categories

#Infection	#Medical environment	#Clinic
#Host	#Human	-

What are isolation sources categories?

[Ref.: #69479]

Global distribution of 16S sequence AM980864 (>99% sequence identity) for Staphylococcus from Microbeatlas

Aquatic Samples	991
Soil Samples	353
Animal Samples	21663
Plant Samples	192
Total Samples	23199

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #5032]	Pathogenicity (human)	yes
[Ref.: #5032]	Pathogenicity (animal)	yes
[Ref.: #5032]	Biosafety level	2	Risk group (German classification) According to TRBA 466

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #20218]	Staphylococcus aureus partial 16S rRNA gene, strain ATCC 43300	AM980864	1519	ENA	1280 tax ID	*

Genome sequence information:

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #66792]	Staphylococcus aureus ATCC 43300	GCA_003052445	contig	GenBank	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus strain ATCC 43300	1280.16403	wgs	PATRIC	1280 tax ID	*

Data predicted using genome information as a basis Genome-based predictions

	Trait	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Staphylococcus aureus strain ATCC 43300 PATRIC: 1280.16403
[Ref.: #69481]	spore-forming	no	91	no

	Trait	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Staphylococcus aureus strain ATCC 43300 PATRIC: 1280.16403
[Ref.: #69480]	motile	no	90.468	no
[Ref.: #69480]	gram-positive	yes	88.437	no
[Ref.: #69480]	anaerobic	no	99.595	no
[Ref.: #69480]	aerobic	yes	90.59	no
[Ref.: #69480]	halophile	yes	93.319	no
[Ref.: #69480]	spore-forming	no	93.412	no
[Ref.: #69480]	thermophile	no	99.652	yes
[Ref.: #69480]	glucose-util	yes	89.015	no
[Ref.: #69480]	flagellated	no	91.773	no
[Ref.: #69480]	glucose-ferment	yes	85.099	yes

Availability in culture collections External links

[Ref.: #5032]

Culture collection no.

DSM 13661, ATCC 43300, CCUG 41586, LMG 15975, WDCM 00211

[Ref.: #83603]

SI-ID 13985

Literature:

Only first 10 entries are displayed. Click here to see all.

	Title	Authors	Journal	DOI	Year
Pathogenicity	Crude metabolites from endophytic fungi inhabiting Cameroonian Annona muricata inhibit the causative agents of urinary tract infections.	Yimgang LV, Kouipou Toghueo RM, Mbekou IMK, Dize D, Boyom FF	PLoS One	10.1371/journal.pone.0267246	2022	*
Pathogenicity	Comparison of peaks in the matrix-assisted laser desorption ionization time-of-flight mass spectrometry spectra of Staphylococcus aureus grown on various blood agar plates.	Kim JM, Chung SH, Kim I, Kim JS	J Microbiol Methods	10.1016/j.mimet.2022.106471	2022	*
Stress	Oxidative Stress-Mediated Antibacterial Activity of the Total Flavonoid Extracted from the Agrimonia pilosa Ledeb. in Methicillin-Resistant Staphylococcusaureus (MRSA).	He L, Cheng H, Chen F, Song S, Zhang H, Sun W, Bao X, Zhang H, He C	Vet Sci	10.3390/vetsci9020071	2022	*
Pathogenicity	Ellagic acid-rich Pomegranate extracts synergizes moxifloxacin against methicillin resistance Staphylococcus aureus (MRSA).	Dahash SL, Al-Windy SB, Al-Kuraishi AH, Hussien NR, Al-Niemi MS, Al-Kuraishy HM	J Pak Med Assoc		2021	*
Pathogenicity	Identification of Novel Antistaphylococcal Hit Compounds Targeting Sortase A.	Volynets G, Vyshniakova H, Nitulescu G, Nitulescu GM, Ungurianu A, Margina D, Moshynets O, Bdzhola V, Koleiev I, Iungin O, Tarnavskiy S, Yarmoluk S	Molecules	10.3390/molecules26237095	2021	*
Pathogenicity	Evaluation of the MRSA/SA ELITe MGB Assay for the Detection of Staphylococcus aureus in Bone and Joint Infections.	Labetoulle R, Rigaill J, Lleres-Vadeboin M, Grattard F, Pozzetto B, Cazorla C, Botelho-Nevers E, Boyer B, Dupieux-Chabert C, Laurent F, Verhoeven PO, Carricajo A	J Clin Microbiol	10.1128/JCM.00835-21	2021	*
Pathogenicity	Novel Hybrid Peptide Cathelicidin 2 (1-13)-Thymopentin (TP5) and Its Derived Peptides with Effective Antibacterial, Antibiofilm, and Anti-Adhesion Activities.	Guo HN, Tong YC, Wang HL, Zhang J, Li ZX, Abbas Z, Yang TT, Liu MY, Chen PY, Hua ZC, Yan XN, Cheng Q, Ahmat M, Wang JY, Zhang LL, Wei XB, Liao XD, Zhang RJ	Int J Mol Sci	10.3390/ijms222111681	2021	*
Pathogenicity	Identification of the antibacterial mechanism of cryptotanshinone on methicillin-resistant Staphylococcus aureus using bioinformatics analysis.	Zhong J, Wang H, Zhuang Y, Shen Q	Sci Rep	10.1038/s41598-021-01121-9	2021	*
Pathogenicity	Bruguiera gymnorhiza (L.) Lam. at the Forefront of Pharma to Confront Zika Virus and Microbial Infections-An In Vitro and In Silico Perspective.	Bibi Sadeer N, Haddad JG, Oday Ezzat M, Despres P, Abdallah HH, Zengin G, Uysal A, El Kalamouni C, Gallo M, Montesano D, Mahomoodally MF	Molecules	10.3390/molecules26195768	2021	*
Metabolism	Antimicrobial photodynamic therapy (aPDT) with curcumin controls intradermal infection by Staphylococcus aureus in mice with type 1 diabetes mellitus: a pilot study.	Muniz IPR, Galantini MPL, Ribeiro IS, Goncalves CV, Dos Santos DP, Moura TC, Silva ES, Silva NR, Cipriano BP, Correia TML, de Jesus Soares T, de Freitas LM, Costa DJ, da Silva RAA	J Photochem Photobiol B	10.1016/j.jphotobiol.2021.112325	2021	*
Proteome	Dereplication of antimicrobial biosurfactants from marine bacteria using molecular networking.	Patino AD, Montoya-Giraldo M, Quintero M, Lopez-Parra LL, Blandon LM, Gomez-Leon J	Sci Rep	10.1038/s41598-021-95788-9	2021	*
Pathogenicity	Novel Phenyl-Based Bis-quaternary Ammonium Compounds as Broad-Spectrum Biocides.	Frolov NA, Fedoseeva KA, Hansford KA, Vereshchagin AN	ChemMedChem	10.1002/cmdc.202100284	2021	*
Pathogenicity	Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity.	Patel B, Zunk M, Grant G, Rudrawar S	Bioorg Med Chem Lett	10.1016/j.bmcl.2021.127853	2021	*
Phylogeny	Gene-targeted molecular phylogeny, phytochemical analysis, antibacterial and antifungal activities of some medicinal plant species cultivated in Egypt.	Omar HS, Elsayed TR, Reyad NEA, Shamkh IM, Sedeek MS	Phytochem Anal	10.1002/pca.3018	2020	*
Pathogenicity	A Novel Dicationic Boron Dipyrromethene-based Photosensitizer for Antimicrobial Photodynamic Therapy against Methicillin-Resistant Staphylococcus aureus.	Dharmaratne P, Yu L, Wong RC, Chan BC, Lau KM, Wang B, Lau CBS, Fung KP, Ng DK, Ip M	Curr Med Chem	10.2174/0929867328666201208095105	2021	*
Pathogenicity	Total Syntheses of Prenylated Isoflavones from Erythrina sacleuxii and Their Antibacterial Activity: 5-Deoxy-3'-prenylbiochanin A and Erysubin F.	Kwesiga G, Kelling A, Kersting S, Sperlich E, von Nickisch-Rosenegk M, Schmidt B	J Nat Prod	10.1021/acs.jnatprod.0c00932	2020	*
Pathogenicity	Synthesis and evaluation of antimicrobial and anticancer activities of 3-phenyl-1-phenylsulfonyl pyrazoles containing an aminoguanidine moiety.	Huang Y, Hu H, Yan R, Lin L, Song M, Yao X	Arch Pharm (Weinheim)	10.1002/ardp.202000165	2020	*
Transcriptome	Transcriptomic and proteomic profiling response of methicillin-resistant Staphylococcus aureus (MRSA) to a novel bacteriocin, plantaricin GZ1-27 and its inhibition of biofilm formation.	Du H, Zhou L, Lu Z, Bie X, Zhao H, Niu YD, Lu F	Appl Microbiol Biotechnol	10.1007/s00253-020-10589-w	2020	*
Phylogeny	Streptomyces sp. 6E3 antimicrobial activity isolated from mineral concentrate.	Ampuero A, Rojas R, Ruiz C, Hurtado J	Rev Peru Med Exp Salud Publica	10.17843/rpmesp.2020.371.4505	2020	*
Pathogenicity	Evaluate the Effect of Zinc Oxide and Silver Nanoparticles on Biofilm and icaA Gene Expression in Methicillin-Resistant Staphylococcus aureus Isolated From Burn Wound Infection.	Shakerimoghaddam A, Razavi D, Rahvar F, Khurshid M, Ostadkelayeh SM, Esmaeili SA, Khaledi A, Eshraghi M	J Burn Care Res	10.1093/jbcr/iraa085	2020	*
Pathogenicity	In Vitro Antimicrobial Activity of a New Ophthalmic Solution Containing Hexamidine Diisethionate 0.05% (Keratosept).	Pinna A, Donadu MG, Usai D, Dore S, Boscia F, Zanetti S	Cornea	10.1097/ICO.0000000000002375	2020	*
Pathogenicity	Drug repurposing approach to target FtsZ cell division protein from Salmonella Typhi.	Naz F, Mashkoor M, Sharma P, Haque MA, Kapil A, Kumar M, Kaur P, Abdul Samath E	Int J Biol Macromol	10.1016/j.ijbiomac.2020.05.063	2020	*
Pathogenicity	A potent enzybiotic against methicillin-resistant Staphylococcus aureus.	Kaur J, Singh P, Sharma D, Harjai K, Chhibber S	Virus Genes	10.1007/s11262-020-01762-4	2020	*
Pathogenicity	Chemical constituents of Clausena lenis.	Wongthet N, Sanevas N, Schinnerl J, Brecker L, Santimaleeworagun W, Rosenau T, Bacher M, Vajrodaya S	Nat Prod Res	10.1080/14786419.2020.1747455	2020	*
Phylogeny	Antimicrobial biosynthetic potential and diversity of culturable soil actinobacteria from forest ecosystems of Northeast India.	Sharma P, Thakur D	Sci Rep	10.1038/s41598-020-60968-6	2020	*
Pathogenicity	Phytochemical analyses and antibacterial activities of Erodium, Euphorbia, Logoecia and Tamarix species.	Al-Hadid KJ, Al-Karablieh N, Sharab A, Mutlak I	J Infect Dev Ctries	10.3855/jidc.11776	2019	*
Pathogenicity	Antagonistic Effect of Colistin on Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus in In Vitro and In Vivo Studies.	Choi S, Moon SM, Park SJ, Lee SC, Jung KH, Sung HS, Kim MN, Jung J, Kim MJ, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS, Chong YP	Antimicrob Agents Chemother	10.1128/AAC.01925-19	2020	*
Pathogenicity	Improved beta-Lactam Susceptibility Against ica-Dependent Biofilm-Embedded Staphylococcus aureus by 2-Aminothiazole.	Kirmusaoglu S	Clin Lab	10.7754/Clin.Lab.2020.191112	2020	*
Pathogenicity	Smart antimicrobial efficacy employing pH-sensitive ZnO-doped diamond-like carbon coatings.	Buchegger S, Kamenac A, Fuchs S, Herrmann R, Houdek P, Gorzelanny C, Obermeier A, Heller S, Burgkart R, Stritzker B, Wixforth A, Westerhausen C	Sci Rep	10.1038/s41598-019-53521-7	2019	*
Phylogeny	GC-IMS headspace analyses allow early recognition of bacterial growth and rapid pathogen differentiation in standard blood cultures.	Drees C, Vautz W, Liedtke S, Rosin C, Althoff K, Lippmann M, Zimmermann S, Legler TJ, Yildiz D, Perl T, Kunze-Szikszay N	Appl Microbiol Biotechnol	10.1007/s00253-019-10181-x	2019	*
Pathogenicity	Antibacterial, Antibiofilm, Antiquorum Sensing, Antimotility, and Antioxidant Activities of Green Fabricated Ag, Cu, TiO2, ZnO, and Fe3O4 NPs via Protoparmeliopsis muralis Lichen Aqueous Extract against Multi-Drug-Resistant Bacteria.	Alavi M, Karimi N, Valadbeigi T	ACS Biomater Sci Eng	10.1021/acsbiomaterials.9b00274	2019	*
Pathogenicity	Polysaccharide-based liquid storage and transport media for non-refrigerated preservation of bacterial pathogens.	Hutchison JR, Brooks SM, Kennedy ZC, Pope TR, Deatherage Kaiser BL, Victry KD, Warner CL, Oxford KL, Omberg KM, Warner MG	PLoS One	10.1371/journal.pone.0221831	2019	*
Pathogenicity	In vitro antimicrobial activity of a new ophthalmic solution containing povidone-iodine 0.6% (IODIM((R)) ).	Pinna A, Donadu MG, Usai D, Dore S, D'Amico-Ricci G, Boscia F, Zanetti S	Acta Ophthalmol	10.1111/aos.14243	2019	*
Phylogeny	New Naphtho-gamma-Pyrones Isolated from Marine-Derived Fungus Penicillium sp. HK1-22 and Their Antimicrobial Activities.	Zheng YY, Liang ZY, Shen NX, Liu WL, Zhou XJ, Fu XM, Chen M, Wang CY	Mar Drugs	10.3390/md17060322	2019	*
Pathogenicity	Internalization, distribution, and activity of peptide H2 against the intracellular multidrug-resistant bovine mastitis-causing bacterium Staphylococcus aureus.	Wang X, Teng D, Wang X, Hao Y, Chen H, Mao R, Wang J	Sci Rep	10.1038/s41598-019-44459-x	2019	*
Pathogenicity	Bactericidal and cytotoxic activity of a diarylheptanoid (etlingerin) isolated from a ginger (Etlingera pubescens) endemic to Borneo.	Daniel-Jambun D, Ong KS, Lim YY, Tan JBL, Yap SW, Lee SM	J Appl Microbiol	10.1111/jam.14287	2019	*
Pathogenicity	Sensitizing of beta-lactam resistance by tannic acid in methicillin-resistant S. aureus.	Kirmusaoglu S	World J Microbiol Biotechnol	10.1007/s11274-019-2637-6	2019	*
Metabolism	Albumycin, a new isoindolequinone from Streptomyces albus J1074 harboring the fluostatin biosynthetic gene cluster.	Huang C, Yang C, Zhang W, Zhu Y, Ma L, Fang Z, Zhang C	J Antibiot (Tokyo)	10.1038/s41429-019-0161-4	2019	*
Enzymology	Chemical constituents from leaves and trunk bark of Rinorea oblongifolia (Violaceae).	Munvera AM, Ouahouo BMW, Mkounga P, Mbekou MIK, Nuzhat S, Choudhary MI, Nkengfack AE	Nat Prod Res	10.1080/14786419.2019.1573230	2019	*
Metabolism	Molecular Identification and Antimicrobial Activity of Vaginal Lactobacillus sp.	Eryilmaz M, Gurpinar SS, Palabiyik IM, Guriz H, Gerceker D	Curr Pharm Biotechnol	10.2174/1389201020666190110164123	2018	*
Pathogenicity	Isothiazolopyridine Mannich bases and their antibacterial effect.	Swiatek P, Strzelecka M	Adv Clin Exp Med	10.17219/acem/99310	2019	*
Pathogenicity	Potential Properties of Lactobacillus plantarum F-10 as a Bio-control Strategy for Wound Infections.	Onbas T, Osmanagaoglu O, Kiran F	Probiotics Antimicrob Proteins	10.1007/s12602-018-9486-8	2019	*
Pathogenicity	Iodine-supported titanium implants have good antimicrobial attachment effects.	Inoue D, Kabata T, Kajino Y, Shirai T, Tsuchiya H	J Orthop Sci	10.1016/j.jos.2018.10.010	2018	*
Pathogenicity	Biological value and chemical components of essential oils of sweet basil (Ocimum basilicum L.) grown with organic fertilization sources.	Yaldiz G, Camlica M, Ozen F	J Sci Food Agric	10.1002/jsfa.9468	2018	*
Pathogenicity	Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus.	Tkhilaishvili T, Lombardi L, Klatt AB, Trampuz A, Di Luca M	Int J Antimicrob Agents	10.1016/j.ijantimicag.2018.09.006	2018	*
Pathogenicity	Antiplanktonic, antibiofilm, antiswarming motility and antiquorum sensing activities of green synthesized Ag-TiO2, TiO2-Ag, Ag-Cu and Cu-Ag nanocomposites against multi-drug-resistant bacteria.	Alavi M, Karimi N	Artif Cells Nanomed Biotechnol	10.1080/21691401.2018.1496923	2018	*
Pathogenicity	Can dalbavancin be used as a catheter lock solution?	Diaz-Ruiz C, Alonso B, Cercenado E, Cruces R, Bouza E, Munoz P, Guembe M	J Med Microbiol	10.1099/jmm.0.000749	2018	*
Pathogenicity	Antibacterial 3,6-Disubstituted 4-Hydroxy-5,6-dihydro-2H-pyran-2-ones from Serratia plymuthica MF371-2.	Bjerketorp J, Levenfors JJ, Sahlberg C, Nord CL, Andersson PF, Guss B, Oberg B, Broberg A	J Nat Prod	10.1021/acs.jnatprod.7b00565	2017	*
Pathogenicity	Use of the Antimicrobial Peptide Sublancin with Combined Antibacterial and Immunomodulatory Activities To Protect against Methicillin-Resistant Staphylococcus aureus Infection in Mice.	Wang S, Wang Q, Zeng X, Ye Q, Huang S, Yu H, Yang T, Qiao S	J Agric Food Chem	10.1021/acs.jafc.7b02592	2017	*
Pathogenicity	Biological and Chemical Diversity of Bacteria Associated with a Marine Flatworm.	Lin HN, Wang KL, Wu ZH, Tian RM, Liu GZ, Xu Y	Mar Drugs	10.3390/md15090281	2017	*
Pathogenicity	Investigation of Antimicrobial, Antioxidant, and Xanthine Oxidase--Inhibitory Activities of Phellinus (Agaricomycetes) Mushroom Species Native to Central Europe.	Kovacs B, Zomborszki ZP, Orban-Gyapai O, Csupor-Loffler B, Liktor-Busa E, Lazar A, Papp V, Urban E, Hohmann J, Vanyolos A	Int J Med Mushrooms	10.1615/IntJMedMushrooms.v19.i5.10	2017	*
Pathogenicity	Evaluation of bactericidal and anti-biofilm properties of a novel surface-active organosilane biocide against healthcare associated pathogens and Pseudomonas aeruginosa biolfilm.	Murray J, Muruko T, Gill CIR, Kearney MP, Farren D, Scott MG, McMullan G, Ternan NG	PLoS One	10.1371/journal.pone.0182624	2017	*
Pathogenicity	Role of Daptomycin on Burn Wound Healing in an Animal Methicillin-Resistant Staphylococcus aureus Infection Model.	Simonetti O, Lucarini G, Orlando F, Pierpaoli E, Ghiselli R, Provinciali M, Castelli P, Guerrieri M, Di Primio R, Offidani A, Giacometti A, Cirioni O	Antimicrob Agents Chemother	10.1128/AAC.00606-17	2017	*
Pathogenicity	Adsorption and photocatalysis efficiency of magnetite quantum dots anchored tin dioxide nanofibers for removal of mutagenic compound: Toxicity evaluation and antibacterial activity.	Fakhri A, Naji M, Nejad PA	J Photochem Photobiol B	10.1016/j.jphotobiol.2017.05.041	2017	*
Pathogenicity	Isolation, Purification, and Characterization of Five Active Diketopiperazine Derivatives from Endophytic Streptomyces SUK 25 with Antimicrobial and Cytotoxic Activities.	Alshaibani M, Zin NM, Jalil J, Sidik N, Ahmad SJ, Kamal N, Edrada-Ebel R	J Microbiol Biotechnol	10.4014/jmb.1608.08032	2017	*
Pathogenicity	Effect of GNP functionalisation and multiple N-methylation of beta-amyloid residue (32-37) on Gram-positive bacterium.	Hemmaragala NM, Abrahamse H, George BP	IET Nanobiotechnol	10.1049/iet-nbt.2016.0083	2017	*
Pathogenicity	Ultraviolet/ultrasound-activated persulfate for degradation of drug by zinc selenide quantum dots: Catalysis and microbiology study.	Fakhri A, Naji M, Tahami S	J Photochem Photobiol B	10.1016/j.jphotobiol.2017.04.024	2017	*
Phylogeny	Streptomyces sp. AT37 isolated from a Saharan soil produces a furanone derivative active against multidrug-resistant Staphylococcus aureus.	Driche EH, Sabaou N, Bijani C, Zitouni A, Pont F, Mathieu F, Badji B	World J Microbiol Biotechnol	10.1007/s11274-017-2265-y	2017	*
Enzymology	Penicilones A-D, Anti-MRSA Azaphilones from the Marine-Derived Fungus Penicillium janthinellum HK1-6.	Chen M, Shen NX, Chen ZQ, Zhang FM, Chen Y	J Nat Prod	10.1021/acs.jnatprod.6b01179	2017	*
Pathogenicity	Transcriptome analysis of methicillin-resistant Staphylococcus aureus in response to stigmasterol and lupeol.	Adnan SN, Ibrahim N, Yaacob WA	J Glob Antimicrob Resist	10.1016/j.jgar.2016.10.006	2016	*
Pathogenicity	Effects of Luteolin and Quercetin in Combination with Some Conventional Antibiotics against Methicillin-Resistant Staphylococcus aureus.	Usman Amin M, Khurram M, Khan TA, Faidah HS, Ullah Shah Z, Ur Rahman S, Haseeb A, Ilyas M, Ullah N, Umar Khayam SM, Iriti M	Int J Mol Sci	10.3390/ijms17111947	2016	*
Pathogenicity	Amphiphilic azobenzene-neomycin conjugate self-assembles into nanostructures and transports plasmid DNA efficiently into the mammalian cells.	Yadav S, Deka SR, Jha D, Gautam HK, Sharma AK	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2016.09.008	2016	*
Pathogenicity	Fosfomycin Addition to Poly(D,L-Lactide) Coating Does Not Affect Prophylaxis Efficacy in Rat Implant-Related Infection Model, But That of Gentamicin Does.	Gulcu A, Akman A, Demirkan AF, Yorukoglu AC, Kaleli I, Bir F	PLoS One	10.1371/journal.pone.0165544	2016	*
Pathogenicity	Two new benzoate derivatives and one new phenylacetate derivative from a marine-derived fungus Engyodontium album.	Wang W, Chen R, Luo Z, Wang W, Chen J	Nat Prod Res	10.1080/14786419.2016.1242002	2016	*
Pathogenicity	Effects of Piper cubeba L. essential oil on methicillin-resistant Staphylococcus aureus: an AFM and TEM study.	Alharbi NS, Khaled JM, Alzaharni KE, Mothana RA, Alsaid MS, Alhoshan M, Dass LA, Kadaikunnan S, Alobaidi AS	J Mol Recognit	10.1002/jmr.2564	2016	*
Pathogenicity	Membrane Destruction and DNA Binding of Staphylococcus aureus Cells Induced by Carvacrol and Its Combined Effect with a Pulsed Electric Field.	Wang LH, Wang MS, Zeng XA, Zhang ZH, Gong DM, Huang YB	J Agric Food Chem	10.1021/acs.jafc.6b02507	2016	*
Pathogenicity	EFFECT OF LINEZOLID ALONE AND IN COMBINATION WITH OTHER ANTIBIOTICS, ON METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS.	Yehia H, El Said M, Azmy M, Badawy M, Mansy S, Gohar H, Madany N	J Egypt Soc Parasitol	10.12816/0026150	2016	*
Pathogenicity	In Vitro and In Vivo Effectiveness of an Innovative Silver-Copper Nanoparticle Coating of Catheters To Prevent Methicillin-Resistant Staphylococcus aureus Infection.	Ballo MK, Rtimi S, Pulgarin C, Hopf N, Berthet A, Kiwi J, Moreillon P, Entenza JM, Bizzini A	Antimicrob Agents Chemother	10.1128/AAC.00959-16	2016	*
Pathogenicity	In Vivo Assessment of Phage and Linezolid Based Implant Coatings for Treatment of Methicillin Resistant S. aureus (MRSA) Mediated Orthopaedic Device Related Infections.	Kaur S, Harjai K, Chhibber S	PLoS One	10.1371/journal.pone.0157626	2016	*
Phylogeny	Isolation and characterization of cyclo-(tryptophanyl-prolyl) and chloramphenicol from Streptomyces sp. SUK 25 with antimethicillin-resistant Staphylococcus aureus activity.	Alshaibani MM, Jalil J, Sidik NM, Edrada-Ebel R, Zin NM	Drug Des Devel Ther	10.2147/DDDT.S101212	2016	*
Pathogenicity	Mechanism of synergy between SIPI-8294 and beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.	He M, Shao L, Liu Q, Li J, Lin H, Jing L, Li M, Chen D	Lett Appl Microbiol	10.1111/lam.12583	2016	*
Biotechnology	Effect of licorice extract on cell viability, biofilm formation and exotoxin production by Staphylococcus aureus.	Rohinishree YS, Negi PS	J Food Sci Technol	10.1007/s13197-015-2131-6	2015	*
Lipids	Temperature-mediated variations in cellular membrane fatty acid composition of Staphylococcus aureus in resistance to pulsed electric fields.	Wang LH, Wang MS, Zeng XA, Liu ZW	Biochim Biophys Acta	10.1016/j.bbamem.2016.05.003	2016	*
Pathogenicity	Bactericidal activity and mechanism of action of copper-sputtered flexible surfaces against multidrug-resistant pathogens.	Ballo MK, Rtimi S, Mancini S, Kiwi J, Pulgarin C, Entenza JM, Bizzini A	Appl Microbiol Biotechnol	10.1007/s00253-016-7450-7	2016	*
Pathogenicity	[Protective effect of pretreatment with TLR2 agonist Pam3Csk4 on mice challenged by methicillin-resistant Staphylococcus aureus].	Chen Y, Chen H, Deng L, Gui X, Yu L, Xiong Z, Min W, Wu X	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi		2016	*
Metabolism	A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model.	Estelles A, Woischnig AK, Liu K, Stephenson R, Lomongsod E, Nguyen D, Zhang J, Heidecker M, Yang Y, Simon RJ, Tenorio E, Ellsworth S, Leighton A, Ryser S, Gremmelmaier NK, Kauvar LM	Antimicrob Agents Chemother	10.1128/AAC.02588-15	2016	*
Pathogenicity	Antibiotic additive and synergistic action of rutin, morin and quercetin against methicillin resistant Staphylococcus aureus.	Amin MU, Khurram M, Khattak B, Khan J	BMC Complement Altern Med	10.1186/s12906-015-0580-0	2015	*
Pathogenicity	New erythromycin derivatives enhance beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.	Li Z, He M, Dong X, Lin H, Ge H, Shen S, Li J, Ye RD, Chen D	Lett Appl Microbiol	10.1111/lam.12378	2015	*
Pathogenicity	Antibacterial activity of three newly-synthesized chalcones & synergism with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.	Bozic DD, Milenkovic M, Ivkovic B, Cirkovic I	Indian J Med Res	IndianJMedRes_2014_140_1_130_140100	2014	*
Pathogenicity	Eradication of methicillin-resistant Staphylococcus aureus infection by nanoliposomes loaded with gentamicin and oleic acid.	Atashbeyk DG, Khameneh B, Tafaghodi M, Fazly Bazzaz BS	Pharm Biol	10.3109/13880209.2014.895018	2014	*
Pathogenicity	Newly-synthesized chalcones-inhibition of adherence and biofilm formation of methicillin-resistant Staphylococcus aureus.	Bozic DD, Milenkovic M, Ivkovic B, Cirkovic I	Braz J Microbiol	10.1590/s1517-83822014000100038	2014	*
Metabolism	Study of the anti-MRSA activity of Rhizoma coptidis by chemical fingerprinting and broth microdilution methods.	Luo JY, Yan D, Yang MH	Chin J Nat Med	10.1016/S1875-5364(14)60049-2	2014	*
Pathogenicity	Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus.	Khameneh B, Iranshahy M, Ghandadi M, Ghoochi Atashbeyk D, Fazly Bazzaz BS, Iranshahi M	Drug Dev Ind Pharm	10.3109/03639045.2014.920025	2014	*
Pathogenicity	High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.	Mihailescu R, Furustrand Tafin U, Corvec S, Oliva A, Betrisey B, Borens O, Trampuz A	Antimicrob Agents Chemother	10.1128/AAC.02420-12	2014	*
Pathogenicity	Previous infection with Staphylococcus aureus strains attenuated experimental encephalomyelitis.	Franca TG, Chiuso-Minicucci F, Zorzella-Pezavento SF, Ishikawa LL, da Rosa LC, Colavite PM, Marques C, Ikoma MR, da Cunha Mde L, Sartori A	BMC Neurosci	10.1186/1471-2202-15-8	2014	*
Pathogenicity	Antibacterial activity of 2-alkynoic fatty acids against multidrug-resistant bacteria.	Sanabria-Rios DJ, Rivera-Torres Y, Maldonado-Dominguez G, Dominguez I, Rios C, Diaz D, Rodriguez JW, Altieri-Rivera JS, Rios-Olivares E, Cintron G, Montano N, Carballeira NM	Chem Phys Lipids	10.1016/j.chemphyslip.2013.12.006	2013	*
Pathogenicity	Long-lasting in vivo and in vitro antibacterial ability of nanostructured titania coating incorporated with silver nanoparticles.	Cheng H, Li Y, Huo K, Gao B, Xiong W	J Biomed Mater Res A	10.1002/jbm.a.35019	2013	*
Enzymology	Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model.	Baldoni D, Furustrand Tafin U, Aeppli S, Angevaare E, Oliva A, Haschke M, Zimmerli W, Trampuz A	Int J Antimicrob Agents	10.1016/j.ijantimicag.2013.05.019	2013	*
Pathogenicity	Effects of 5-aminolevulinic acid-mediated photodynamic therapy on antibiotic-resistant staphylococcal biofilm: an in vitro study.	Li X, Guo H, Tian Q, Zheng G, Hu Y, Fu Y, Tan H	J Surg Res	10.1016/j.jss.2013.03.094	2013	*
Pathogenicity	Transcriptional profiles of the response of methicillin-resistant Staphylococcus aureus to pentacyclic triterpenoids.	Chung PY, Chung LY, Navaratnam P	PLoS One	10.1371/journal.pone.0056687	2013	*
Enzymology	Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.	Chhibber S, Kaur T, Sandeep Kaur	PLoS One	10.1371/journal.pone.0056022	2013	*
Pathogenicity	Daptomycin versus vancomycin in treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.	Bardak-Ozcem S, Turhan T, Sipahi OR, Arda B, Pullukcu H, Yamazhan T, Isikgoz-Tasbakan M, Sipahi H, Ulusoy S	Antimicrob Agents Chemother	10.1128/AAC.01996-12	2013	*
Pathogenicity	Efficacy of leukocyte- and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model.	Li GY, Yin JM, Ding H, Jia WT, Zhang CQ	J Orthop Res	10.1002/jor.22299	2012	*
Pathogenicity	Human beta-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation.	Zhu C, Tan H, Cheng T, Shen H, Shao J, Guo Y, Shi S, Zhang X	J Surg Res	10.1016/j.jss.2012.11.048	2012	*
Pathogenicity	Four new antibacterial xanthones from the marine-derived actinomycetes Streptomyces caelestis.	Liu LL, Xu Y, Han Z, Li YX, Lu L, Lai PY, Zhong JL, Guo XR, Zhang XX, Qian PY	Mar Drugs	10.3390/md10112571	2012	*
Pathogenicity	Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.	Calik S, Turhan T, Yurtseven T, Sipahi OR, Buke C	Med Sci Monit	10.12659/msm.883528	2012	*
Pathogenicity	In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms.	Mataraci E, Dosler S	Antimicrob Agents Chemother	10.1128/AAC.01180-12	2012	*
Pathogenicity	Methicillin-resistant Staphylococcus aureus phage plaque size enhancement using sublethal concentrations of antibiotics.	Kaur S, Harjai K, Chhibber S	Appl Environ Microbiol	10.1128/AEM.02371-12	2012	*
Pathogenicity	Comparison of methods for evaluation of the bactericidal activity of copper-sputtered surfaces against methicillin-resistant Staphylococcus aureus.	Rio L, Kusiak-Nejman E, Kiwi J, Betrisey B, Pulgarin C, Trampuz A, Bizzini A	Appl Environ Microbiol	10.1128/AEM.02266-12	2012	*
Enzymology	Biological activities of extracts from Chenopodium ambrosioides Lineu and Kielmeyera neglecta Saddi.	Sousa ZL, de Oliveira FF, da Conceicao AO, Silva LA, Rossi MH, Santos Jda S, Andrioli JL	Ann Clin Microbiol Antimicrob	10.1186/1476-0711-11-20	2012	*
Pathogenicity	Synergistic activities of a silver(I) glutamic acid complex and reactive oxygen species (ROS): a novel antimicrobial and chemotherapeutic agent.	Batarseh KI, Smith MA	Curr Med Chem	10.2174/092986712801323216	2012	*
Pathogenicity	Vancomycin MICs of the resistant mutants of S. aureus ATCC43300 vary based on the susceptibility test methods used.	Zhu YL, Mei Q, Hu LF, Cheng J, Ye Y, Li JB	J Antibiot (Tokyo)	10.1038/ja.2012.18	2012	*
Pathogenicity	In vitro study of elution kinetics and bio-activity of meropenem-loaded acrylic bone cement.	Samuel S, Mathew BS, Veeraraghavan B, Fleming DH, Chittaranjan SB, Prakash JA	J Orthop Traumatol	10.1007/s10195-012-0191-1	2012	*
Pathogenicity	Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.	Fernandez J, Abbanat D, Shang W, He W, Amsler K, Hastings J, Queenan AM, Melton JL, Barron AM, Flamm RK, Lynch AS	Antimicrob Agents Chemother	10.1128/AAC.06057-11	2012	*
Metabolism	Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation.	Simonetti O, Cirioni O, Lucarini G, Orlando F, Ghiselli R, Silvestri C, Brescini L, Rocchi M, Provinciali M, Guerrieri M, Di Primio R, Giacometti A, Offidani A	J Antimicrob Chemother	10.1093/jac/dkr440	2011	*
Pathogenicity	The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus.	Tan H, Peng Z, Li Q, Xu X, Guo S, Tang T	Biomaterials	10.1016/j.biomaterials.2011.09.084	2011	*
Phylogeny	[Study of marine actinomycetes isolated from the central coast of Peru and their antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis].	Leon J, Aponte JJ, Rojas R, Cuadra D, Ayala N, Tomas G, Guerrero M	Rev Peru Med Exp Salud Publica	S1726-46342011000200010	2011	*
Enzymology	The antistaphylococcal pharmacodynamics of linezolid alone and in combination with doxycycline in an in vitro dynamic model.	Smirnova MV, Strukova EN, Portnoy YA, Dovzhenko SA, Kobrin MB, Zinner SH, Firsov AA	J Chemother	10.1179/joc.2011.23.3.140	2011	*
Pathogenicity	Synthesis of P-triazinylphosphonium salts--hybrid molecules with potential antimicrobial activity.	Kolesinska B, Motylski R, Kaminski ZJ, Kwinkowski M, Kaca W	Acta Pol Pharm		2011	*
Enzymology	Essential oils of Daucus carota subsp. carota of Tunisia obtained by supercritical carbon dioxide extraction.	Marzouki H, Khaldi A, Falconieri D, Piras A, Marongiu B, Molicotti P, Zanetti S	Nat Prod Commun		2010	*
Pathogenicity	Essential oil composition of leaves of Stachys yemenensis obtained by supercritical CO(2).	Ali NA, Marongiu B, Piras A, Porcedda S, Falconieri D, Molicotti P, Zanetti S	Nat Prod Res	10.1080/14786411003754272	2010	*
Pathogenicity	Superhydrophilicity and antibacterial property of a Cu-dotted oxide coating surface.	Nie Y, Kalapos C, Nie X, Murphy M, Hussein R, Zhang J	Ann Clin Microbiol Antimicrob	10.1186/1476-0711-9-25	2010	*
Pathogenicity	Inhibition of methicillin-resistant Staphylococcus aureus by the compound Qingre granules.	Yu YY, Wang H, Zhang SW, Wang BE	Chin Med J (Engl)		2010	*
Metabolism	Evaluation of Vancoplus versus ceftriaxone against cephalosporin resistance MRSA strain in experimental meningitis model.	Soni A, Chaudhary M, Dwivedi VK, Kumar S, Shrivastava SM	Cardiovasc Hematol Disord Drug Targets	10.2174/187152910791292466	2010	*
Pathogenicity	Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA).	Karska-Wysocki B, Bazo M, Smoragiewicz W	Microbiol Res	10.1016/j.micres.2009.11.008	2010	*
Pathogenicity	The impact of duration of antibiotic exposure on bacterial resistance predictions using in vitro dynamic models.	Smirnova MV, Vostrov SN, Strukova EV, Dovzhenko SA, Kobrin MB, Portnoy YA, Zinner SH, Firsov AA	J Antimicrob Chemother	10.1093/jac/dkp287	2009	*
Enzymology	Linezolid pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.	Strukova EN, Smirnova MV, Vostrov SN, Lubenko IY, Firsov AA, Zinner SH, Portnoy YA	Int J Antimicrob Agents	10.1016/j.ijantimicag.2008.09.006	2008	*
Enzymology	Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.	Lubenko IY, Strukova EV, Smirnova MV, Vostrov SN, Portnoy YA, Zinner SH, Firsov AA	J Antimicrob Chemother	10.1093/jac/dkn288	2008	*
Pathogenicity	Antimicrobial activity screening of some sulfonamide derivatives on some Nocardia species and isolates.	Isik K, Ozdemir-Kocak F	Microbiol Res	10.1016/j.micres.2006.11.002	2007	*
Enzymology	Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.	Sipahi OR, Arda B, Yurtseven T, Sipahi H, Ozgiray E, Suntur BM, Ulusoy S	Int J Antimicrob Agents	10.1016/j.ijantimicag.2005.08.011	2005	*
Pathogenicity	Optimal inoculation methods and quality control for the NCCLS oxacillin agar screen test for detection of oxacillin resistance in Staphylococcus aureus.	Swenson JM, Spargo J, Tenover FC, Ferraro MJ	J Clin Microbiol	10.1128/JCM.39.10.3781-3784.2001	2001	*
Pathogenicity	Synthesis and biological evaluation of antibacterial activity of novel clarithromycin derivatives incorporating 1,2,3-triazole moieties at the 4''- and 11-OH positions.	Qin Y, Sun M, Zhang N, Yang Y, Ma P	Bioorg Chem	10.1016/j.bioorg.2022.106020	2022	*
Metabolism	Heterologous production of active form of beta-lytic protease by Bacillus subtilis and improvement of staphylolytic activity by protein engineering.	Hioki T, Yamashita D, Tohata M, Endo K, Kawahara A, Okuda M	Microb Cell Fact	10.1186/s12934-021-01724-x	2021	*
Pathogenicity	A click chemistry approach to pleuromutilin derivatives, evaluation of anti-MRSA activity and elucidation of binding mode by surface plasmon resonance and molecular docking.	Zhang Z, Zhang ZS, Wang X, Xi GL, Jin Z, Tang YZ	J Enzyme Inhib Med Chem	10.1080/14756366.2021.1977931	2021	*
Pathogenicity	Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus.	Sharma AD, Gutheil WG	Microbiol Spectr	10.1128/spectrum.03726-22	2022	*
Pathogenicity	Bioactive Metabolites of Lactiplantibacillus plantarum K014 Against Methicillin-Resistant Staphylococcus aureus ATCC43300 and In Vitro Evaluation of Its Antibacterial, Antioxidant and Anti-inflammatory Activities.	Mlambo LK, Abbasiliasi S, Tang HW, Ng ZJ, Parumasivam T, Hanafiah KM, Al-Shammary AAK, Tan JS	Curr Microbiol	10.1007/s00284-022-03038-6	2022	*
	An animal derivative-free medium enhances Lactobacillus johnsonii LJO02 supernatant selective efficacy against the methicillin (oxacillin)-resistant Staphylococcus aureus virulence through key-metabolites.	Squarzanti DF, Zanetta P, Ormelli M, Manfredi M, Barberis E, Vanella VV, Amoruso A, Pane M, Azzimonti B	Sci Rep	10.1038/s41598-022-12718-z	2022	*
	Thermal, flammability, and antimicrobial properties of arrowroot (Maranta arundinacea) fiber reinforced arrowroot starch biopolymer composites for food packaging applications.	Tarique J, Sapuan SM, Khalina A, Ilyas RA, Zainudin ES	Int J Biol Macromol	10.1016/j.ijbiomac.2022.05.104	2022	*
	Biosynthesis and Characterization of Silver Nanoparticles Produced by Phormidium ambiguum and Desertifilum tharense Cyanobacteria.	Hanna AL, Hamouda HM, Goda HA, Sadik MW, Moghanm FS, Ghoneim AM, Alenezi MA, Alnomasy SF, Alam P, Elsayed TR	Bioinorg Chem Appl	10.1155/2022/9072508	2022	*
	Fascaplysin derivatives binding to DNA via unique cationic five-ring coplanar backbone showed potent antimicrobial/antibiofilm activity against MRSA in vitro and in vivo.	Wang X, Qiu H, Yang N, Xie H, Liang W, Lin J, Zhu H, Zhou Y, Wang N, Tan X, Zhou J, Cui W, Teng D, Wang J, Liang H	Eur J Med Chem	10.1016/j.ejmech.2021.114099	2022	*
	The Remarkable Antibiofilm Activity of the Sweet Tooth Mushroom, Hydnum repandum (Agaricomycetes), Displaying Synergetic Interactions with Antibiotics.	Dizeci N, Karaca B, Onar O, Cihan AC, Akata I, Yildirim O	Int J Med Mushrooms	10.1615/IntJMedMushrooms.2021040148	2021	*
	Evaluation of the synergistic antimicrobial effect of folk medicinal plants with clindamycin against methicillin-resistant Staphylococcus aureus strains.	Mayyas A, Azzam H, Tayseer I, Al-Karablieh N, Aburjai T	Lett Appl Microbiol	10.1111/lam.13565	2021	*
	Dual-functional hybrid quaternized chitosan/Mg/alginate dressing with antibacterial and angiogenic potential for diabetic wound healing.	Wang M, Yang Y, Yuan K, Yang S, Tang T	J Orthop Translat	10.1016/j.jot.2021.07.006	2021	*
	Characterizations of the endolysin Lys84 and its domains from phage qdsa002 with high activities against Staphylococcus aureus and its biofilms.	Ning H, Lin H, Wang J, He X, Lv X, Ju L	Enzyme Microb Technol	10.1016/j.enzmictec.2021.109809	2021	*
	Antibacterial Activities of Homemade Matrices Miming Essential Oils Compared to Commercial Ones.	Oliveira Ribeiro S, Fontaine V, Mathieu V, Abdesselam Z, Dominique B, Caroline S, Florence S	Antibiotics (Basel)	10.3390/antibiotics10050584	2021	*
	Design, Synthesis, Antibacterial Evaluation and Molecular Docking Studies of Some Newer Baenzothiazole Containing Aryl and Alkaryl Hydrazides.	Gurram SR, Afzal Azam M	Chem Biodivers	10.1002/cbdv.202100117	2021	*
	Assessing the diversity of bacterial communities from marine sponges and their bioactive compounds.	Bibi F, Naseer MI, Azhar EI	Saudi J Biol Sci	10.1016/j.sjbs.2021.03.042	2021	*
	A Study on the Synbiotic Composition of Bifidobacterium bifidum and Fructans from Arctium lappa Roots and Helianthus tuberosus Tubers against Staphylococcus aureus.	Evdokimova SA, Nokhaeva VS, Karetkin BA, Guseva EV, Khabibulina NV, Kornienko MA, Grosheva VD, Menshutina NV, Shakir IV, Panfilov VI	Microorganisms	10.3390/microorganisms9050930	2021	*
	In vitro kinetic release study, antimicrobial activity and in vivo toxicity profile of a kojic acid ester-based nanoemulsion for topical application.	Syed Azhar SNA, Ashari SE, Ahmad S, Salim N	RSC Adv	10.1039/d0ra04807k	2020	*
	Adjunctive Use of Phage Sb-1 in Antibiotics Enhances Inhibitory Biofilm Growth Activity versus Rifampin-Resistant Staphylococcus aureus Strains.	Wang L, Tkhilaishvili T, Trampuz A	Antibiotics (Basel)	10.3390/antibiotics9110749	2020	*
	Synergistic Potential of Antimicrobial Combinations Against Methicillin-Resistant Staphylococcus aureus.	Yu Y, Huang HL, Ye XQ, Cai DT, Fang JT, Sun J, Liao XP, Liu YH	Front Microbiol	10.3389/fmicb.2020.01919	2020	*
	Screening of Indonesian peat soil bacteria producing antimicrobial compounds.	Mahdiyah D, Farida H, Riwanto I, Mustofa M, Wahjono H, Laksana Nugroho T, Reki W	Saudi J Biol Sci	10.1016/j.sjbs.2020.05.033	2020	*
	In Vitro Study To Evaluate the Bioactivity of Freezing a Heparin-Based Dalbavancin Lock Solution.	Rubia M, Cordero A, Perez-Granda MJ, Cercenado E, Pascual C, Munoz P, Guembe M	Antimicrob Agents Chemother	10.1128/AAC.01495-20	2020	*
	Synthesis and In Vitro Photodynamic Activity of Cationic Boron Dipyrromethene-Based Photosensitizers against Methicillin-Resistant Staphylococcus aureus.	Dharmaratne P, Wong RCH, Wang J, Lo PC, Wang B, Chan BCL, Lau KM, Lau CBS, Fung KP, Ip M, Ng DKP	Biomedicines	10.3390/biomedicines8060140	2020	*
	Graphene Decorated Zinc Oxide and Curcumin to Disinfect the Methicillin-Resistant Staphylococcus aureus.	Oves M, Rauf MA, Ansari MO, Aslam Parwaz Khan A, A Qari H, Alajmi MF, Sau S, Iyer AK	Nanomaterials (Basel)	10.3390/nano10051004	2020	*
	Anti-MRSA Activity of Actinomycin X2 and Collismycin A Produced by Streptomyces globisporus WA5-2-37 From the Intestinal Tract of American Cockroach (Periplaneta americana).	Chen Z, Ou P, Liu L, Jin X	Front Microbiol	10.3389/fmicb.2020.00555	2020	*
	Ceftaroline versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in an experimental MRSA meningitis model.	Mermer S, Turhan T, Bolat E, Aydemir S, Yamazhan T, Pullukcu H, Arda B, Sipahi H, Ulusoy S, Sipahi OR	J Glob Antimicrob Resist	10.1016/j.jgar.2020.02.001	2020	*
	Chemovariation and antibacterial activity of extracts and isolated compounds from species of Ixora and Greenea (Ixoroideae, Rubiaceae).	Buathong R, Chamchumroon V, Schinnerl J, Bacher M, Santimaleeworagun W, Kraichak E, Vajrodaya S	PeerJ	10.7717/peerj.6893	2019	*
	Potential antimicrobial effect of plant essential oils and virulence genes expression in methicillin-resistant Staphylococcus aureus isolates.	Gharaibeh MH, Khalifeh MS, Zattout EM, Abu-Qatouseh LF	Vet World	10.14202/vetworld.2020.669-675	2020	*
	Efficient Synthesis of Amine-Linked 2,4,6-Trisubstituted Pyrimidines as a New Class of Bacterial FtsZ Inhibitors.	Chan KF, Sun N, Yan SC, Wong ILK, Lui HK, Cheung KC, Yuan J, Chan FY, Zheng Z, Chan EWC, Chen S, Leung YC, Chan TH, Wong KY	ACS Omega	10.1021/acsomega.7b00701	2017	*
	Biosynthesis of TiO2 and ZnO nanoparticles by Halomonas elongata IBRC-M 10214 in different conditions of medium.	Taran M, Rad M, Alavi M	Bioimpacts	10.15171/bi.2018.10	2017	*
	Resensitization of methicillin-resistant Staphylococcus aureus by amoxapine, an FDA-approved antidepressant.	Wilson TJ, Blackledge MS, Vigueira PA	Heliyon	10.1016/j.heliyon.2017.e00501	2018	*
	Disruption of methicillin-resistant Staphylococcus aureus protein synthesis by tannins.	Adnan SN, Ibrahim N, Yaacob WA	Germs	10.18683/germs.2017.1125	2017	*
	Characterization, antibacterial, total antioxidant, scavenging, reducing power and ion chelating activities of green synthesized silver, copper and titanium dioxide nanoparticles using Artemisia haussknechtii leaf extract.	Alavi M, Karimi N	Artif Cells Nanomed Biotechnol	10.1080/21691401.2017.1408121	2017	*
	Size selectivity in antibiofilm activity of 3-(diphenylphosphino)propanoic acid coated gold nanomaterials against Gram-positive Staphylococcus aureus and Streptococcus mutans.	Ahmed D, Anwar A, Khan AK, Ahmed A, Shah MR, Khan NA	AMB Express	10.1186/s13568-017-0515-x	2017	*
	Antibacterial, Anticancer and Neuroprotective Activities of Rare Actinobacteria from Mangrove Forest Soils.	Azman AS, Othman I, Fang CM, Chan KG, Goh BH, Lee LH	Indian J Microbiol	10.1007/s12088-016-0627-z	2016	*
	Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus.	Chen H, Mao R, Teng D, Wang X, Hao Y, Feng X, Wang J	AMB Express	10.1186/s13568-017-0345-x	2017	*
	Bacterial inhibition potential of quaternised chitosan-coated VICRYL absorbable suture: An in vitro and in vivo study.	Yang Y, Yang SB, Wang YG, Zhang SH, Yu ZF, Tang TT	J Orthop Translat	10.1016/j.jot.2016.10.001	2016	*
	A comparison of the recoverable proportion of methicillin-resistant Staphylococcus aureus from two different types of papers.	Kacmaz B, Gul S	GMS Hyg Infect Control	10.3205/dgkh000266	2016	*
	gamma-Cyclodextrin capped silver nanoparticles for molecular recognition and enhancement of antibacterial activity of chloramphenicol.	Gannimani R, Ramesh M, Mtambo S, Pillay K, Soliman ME, Govender P	J Inorg Biochem	10.1016/j.jinorgbio.2016.01.008	2016	*
	Antibacterial and antifungal activities of new acylated derivatives of epigallocatechin gallate.	Matsumoto Y, Kaihatsu K, Nishino K, Ogawa M, Kato N, Yamaguchi A	Front Microbiol	10.3389/fmicb.2012.00053	2012	*
	Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin.	John AK, Baldoni D, Haschke M, Rentsch K, Schaerli P, Zimmerli W, Trampuz A	Antimicrob Agents Chemother	10.1128/AAC.00047-09	2009	*
	LC-MS profile, in vitro acetylcholinesterase inhibitory, antibacterial and hemostatic properties of Ranunculus bullatus extract.	Lemoui R, Cheriet T, Kahlouche F, Noman L, Seghiri R, Abudunia A	Nat Prod Res	10.1080/14786419.2022.2136661	2022	*
	Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents.	Chai F, Wang J, Zhou KX, Wang SK, Liu YH, Jin Z, Tang YZ	Bioorg Chem	10.1016/j.bioorg.2022.105859	2022	*
	Development of structurally extended benzosiloxaboroles - synthesis and in vitro biological evaluation.	Pacholak P, Krajewska J, Winska P, Dunikowska J, Gogowska U, Mierzejewska J, Durka K, Wozniak K, Laudy AE, Lulinski S	RSC Adv	10.1039/d1ra04127d	2021	*
	Semisynthetic pleuromutilin antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus by targeting 50S ribosomal subunit.	Wang X, Wang R, Zhang ZS, Zhang GY, Jin Z, Shen R, Du D, Tang YZ	Eur J Med Chem	10.1016/j.ejmech.2022.114341	2022	*
	MALDI-TOF MS method for differentiation of methicillin-sensitive and methicillin-resistant Staphylococcus aureus using (E)-Propyl alpha-cyano-4-Hydroxyl cinnamylate.	Gao W, Li B, Ling L, Zhang L, Yu S	Talanta	10.1016/j.talanta.2022.123405	2022	*
	Synthesis, Biological Activity and Molecular Docking Studies of Novel Nicotinic Acid Derivatives.	Paruch K, Biernasiuk A, Khylyuk D, Paduch R, Wujec M, Popiolek L	Int J Mol Sci	10.3390/ijms23052823	2022	*
	Design, synthesis and antibacterial evaluation of pleuromutilin derivatives.	Wu G, Zhu Z, Li J, Luo X, Zhu W, Liao G, Xia J, Zhang W, Pan W, Li T, Wu S	Bioorg Med Chem	10.1016/j.bmc.2022.116676	2022	*
	One new constituent from the stem bark of Chrysophyllum lacourtianum De Wild. (sapotaceae).	Talla RM, Jouda JB, Mawabo IK, Tegasne C, Happi GM, Kapche GDWF, Lenta BN, Sewald N, Wandji J	Nat Prod Res	10.1080/14786419.2021.1986493	2021	*
	Phage-Based Control of Methicillin Resistant Staphylococcus aureus in a Galleria mellonella Model of Implant-Associated Infection.	Materazzi A, Bottai D, Campobasso C, Klatt AB, Cesta N, De Masi M, Trampuz A, Tavanti A, Di Luca M	Int J Mol Sci	10.3390/ijms232314514	2022	*
	Wound swabs versus biopsies to detect methicillin resistant Staphylococcus aureus in experimental equine wounds.	Brock AK, Chamoun-Emanuelli AM, Howard EA, Huntzinger KD, Lawhon SD, Bryan LK, Cosgriff-Hernandez EM, Cohen ND, Whitfield-Cargile CM	Vet Surg	10.1111/vsu.13872	2022	*
	Design, synthesis, and biological evaluation of membrane-active honokiol derivatives as potent antibacterial agents.	Wang Y, Wu P, Liu F, Chen J, Xue J, Qin Y, Chen F, Wang S, Ji L	Eur J Med Chem	10.1016/j.ejmech.2022.114593	2022	*

References

#5032

Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 13661

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#20218

Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )

#55134 Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 41586

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#68375

Automatically annotated from API ID32STA .

#69479

João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

#83603

Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.: StrainInfo: A central database for resolving microbial strain identifiers . ( DOI 10.60712/SI-ID13985.1 )

* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Staphylococcus aureus in external resources:
SILVA
BRENDA
PANGAEA
StrainInfo
GBIF

Staphylococcus aureus strain ATCC 43300

Staphylococcus aureus strain ATCC 43300

Change proposal

Change proposal